Neprilysin Inhibition in Heart Failure with Reduced Ejection Fraction: A Clinical Review

Publisher： John Wiley & Sons Inc

E-ISSN： 1875-9114|277-0008|9|823-837

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.277-0008, Iss.9, 2015-09, pp. : 823-837

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review

By  

Cardiology, Vol. 136, Iss. 3, 2016-10 ,pp. : 192-203

Karger

Access to resources Recommend Favorite

Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 5, 2015-05 ,pp. : 510-517

John Wiley & Sons Inc

Access to resources Recommend Favorite

Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?

By  

Cardiology, Vol. 134, Iss. 3, 2016-03 ,pp. : 311-319

Karger

Access to resources Recommend Favorite

Biomarkers and prognostication in heart failure with reduced and preserved ejection fraction: similar but different?

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 19, Iss. 12, 2017-12 ,pp. : 1648-1650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recovered heart failure with reduced ejection fraction and outcomes: a prospective study

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 19, Iss. 12, 2017-12 ,pp. : 1615-1623

John Wiley & Sons Inc

Access to resources Recommend Favorite